Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  9.00 2.24% 410.00 400.00 420.00 410.00 397.50 397.50 57,476 15:59:04
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 26.2 4.7 9.1 44.9 186

Tristel Share Discussion Threads

Showing 3301 to 3323 of 3450 messages
Chat Pages: 138  137  136  135  134  133  132  131  130  129  128  127  Older
DateSubjectAuthorDiscuss
25/2/2020
08:26
Anyone found the results presentation? "The results presentation will be made available on the Company's website www.tristel.com on the day of results."
piedro
24/2/2020
11:59
Must be one of the best companies I’ve ever invested in back in 2011 as I discuss on different boards you very rarely get get these sort of returns unless you take a long term view. A lot of posters seem to be so impatient and have little understand of the companies they invest in also
best1467
24/2/2020
09:28
Comment today wrt Tristel on Twitter https://twitter.com/CapitalPmh/status/1231850623311794176
brummy_git
24/2/2020
08:19
Well done ... I guess the Covid-19 peak was an aberration and TSTL is now back on its upward trendline. An obvious LTH although I am out ATM.
fizzypop
24/2/2020
08:08
A refreshingly informative Chairman's statement, concise, to the point and without tedious waffle. Congratulations.
piedro
24/2/2020
07:32
Sparkling results. A clean share with no debt. Nice hike in the divi and France looks promising. C'est la vie. Mostly wiping out the competition and this one has further to run.
mach100
24/2/2020
07:29
H1 report Financial highlights · Revenue up 22% to £14.6m (2018: £12m) · Overseas sales up 30% to £8.3m (2018: £6.4m), representing 56% of total sales (2018: 53%) · Gross margin increased to 79% from 78% in 2018 · PBT before share-based payments up 25% to £3.0m (2018: £2.4m). Unadjusted PBT of £2.8m (£2.2m) · EPS before share-based payments up 31% to 5.89p (2018: 4.5p). Unadjusted EPS of 5.37p (2018: 4.05p) · EBITDA before share-based payments up 34% to £4.3m (2018: £3.2m) · EBITDA margin before share-based payments of 29% (2018: 26%) · Interim dividend of 2.34p per share (2018: 2.04p), up 15% · Cash of £4.2m (2018: £4.5m), after £0.6m paid in July to acquire the remaining 80% of Tristel Italia srl. Operational highlights · Successful integration of Tristel Italia srl; · Received further positive feedback from the FDA and data generation for our regulatory submission continues; · Completed the construction and fit-out of a second warehouse and office suite of 23,000 sq ft in Newmarket, Suffolk. Commenting on current trading, Paul Swinney, Chief Executive of Tristel, said: "We are very pleased with our progress in the first half. Sales growth has been above our target range of 10-15% and margins have improved also. "Sales growth in our UK hospital division, which accounts for 86% of all UK sales, was up by 16% half-on-half. NHS stock building in preparation for a no deal Brexit did not influence these results. Two-thirds of the growth in UK hospital sales can be attributed to higher numbers of disinfection procedures across all the clinical areas we target, and one-third to product pricing. Moreover, overseas sales continued to increase at a very healthy rate of 30%. This growth was largely attributable to the establishment (through acquisition) of direct operations in Belgium, Netherlands, France and Italy. "We continue to advance our USA regulatory project and have received further helpful guidance from the FDA to enable us to progress the compilation of our submission dossier. "The development of our Board continues. Dr Bruno Holthof took over the Chair from Paul Barnes at our December AGM. "We are currently experiencing Covid-19. This viral outbreak, together with the ever-present threat of anti-microbial resistance, will be a powerful influence on global healthcare systems for greater investment in infection prevention and control. As a globally recognised infection prevention brand, with some of the world's best-known disinfection technology, there are significant macro factors that will support Tristel's continued progress".
metis20
12/2/2020
22:17
All good shares are crowded. The question is, is it justified? We'll soon find out...
jdh1602
12/2/2020
08:42
5% stop loss triggered so I'm out for a 9% gain. May well return before results on 24 Feb.
fizzypop
12/2/2020
05:54
Tristel Global@TristelGlobal Keep your eye on #2019-nCoV! Ophthalmic medical devices that make direct contact with the eye could be carriers of 2019-nCOV. Tristel Duo OPH can help prevent the spread of 2019-nCoV and other pathogens. #coronavirus
piedro
10/2/2020
17:22
... and likelihood of FDA approval.
metis20
10/2/2020
17:05
Whether overpriced or not depends on coronavirus induced sales growth...
metis20
10/2/2020
16:54
totally overpriced now
onjohn
10/2/2020
16:54
Just starting to look a bit overvalued. it's going up because of the virus but it can't stop people catching it when they sit next to each other on a plane. very slowly taking a few profits, which, as I first bought them at 30p are not looking too small now. I will buy them all back and some more if they drop back too far, which they tend to do every now and then
q2u
10/2/2020
16:45
Closed at 449p up 3.8% for another ATH
fizzypop
10/2/2020
16:37
Looking good on the breakout ;)
banj
07/2/2020
13:45
Interim Results 24-Feb-2020 Closed the week with a 6% rise to 432.50p with an intraday ATH of 435p on Friday.
fizzypop
05/2/2020
19:10
New ATH of 402.5p today.
fizzypop
05/2/2020
11:26
Medimark {now owned by Byotrol} advertising .... MEDIMARK SCIENTIFIC - Human Health @CHEMGENEHLD4 AIRGENE Aerosol Disinfectant is effective against Coronavirus in 15 Minutes (within its recommended application time). - - - - - - - - - - - - - - - - - - - - - - - - - - The Anistel { Tristel} version ... - - - - - - - - - - - - - - - - - - - -
piedro
04/2/2020
15:20
Tristel Global@TristelGlobal Tristel France exhibiting at the CoHygiE day in Harfleur, Normandy 🇫🇷. #WeHaveChemistry # disinfection #infectionprevention
piedro
30/1/2020
12:51
JET is sporicidal, mycobactericidal, virucidal, fungicidal and bactericidal in one minute. It has been tested in accredited laboratories and is proven effective against a wide range of microorganisms Tristel Global @TristelGlobal The outbreak of novel strain ‘2019-novel coronavirus’ (2019n-CoV) has led to at least 17 deaths and more than 550 confirmed cases (on 23 January 2020). #Tristel chlorine dioxide products are virucidal and are effective against all viral strains, including #coronaviruses Https://www.tristel.com/uk/
metis20
24/1/2020
06:15
Well done ... Tristel Global@TristelGlobal The outbreak of novel strain ‘2019-novel coronavirus’ (2019n-CoV) has led to at least 17 deaths and more than 550 confirmed cases (on 23 January 2020). #Tristel chlorine dioxide products are virucidal* and are effective against all viral strains, including #coronaviruses.440;🦠
piedro
16/1/2020
10:33
Clorox, Ecolab, Johnsons & Johnsons are the big American names Also some UK companies eg: Byotrol
piedro
Chat Pages: 138  137  136  135  134  133  132  131  130  129  128  127  Older
ADVFN Advertorial
Your Recent History
LSE
TSTL
Tristel
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200713 00:12:38